Milestone Pharmaceuticals USA Inc.
Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions.
Employment range in NC
Primary site activity
All company activities
Products under development